Efficacy and In Vitro Activity of Novel Antibiotics for Infections With Carbapenem-Resistant Gram-Negative Pathogens

Efficacy and In Vitro Activity of Novel Antibiotics for Infections With Carbapenem-Resistant Gram-Negative Pathogens

Infections by Gram-negative multi-drug resistant (MDR) bacterial species are difficult to treat using available antibiotics. Overuse of carbapenems has contributed to widespread resistance to these antibiotics; as a result, carbapenem-resistant Enterobacterales (CRE), A. baumannii (CRAB), and P. aer...

Full description

Bibliographic Details
Main Authors:	Flora Cruz-López, Adrian Martínez-Meléndez, Rayo Morfin-Otero, Eduardo Rodriguez-Noriega, Héctor J. Maldonado-Garza, Elvira Garza-González
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	carbapenemase drug resistance new antibiotics acinetobacter gram negatives
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2022.884365/full

Similar Items

An Application of Imipenem Discs or <i>P. aeruginosa</i> ATCC 27853 Reference Strain Increases Sensitivity of Carbapenem Inactivation Method for Non-Fermenting Gram-Negative Bacteria
by: Tomasz Bogiel, et al.
Published: (2021-07-01)

Determination of Carbapenem Resistance in Gram-Negative Bacteremia in the Burn Intensive Care Unit
by: Özge ÇAYDAŞI, et al.
Published: (2024-03-01)

Molecular epidemiology of carbapenem-resistant gram-negative bacilli in Ecuador
by: Claudia Soria-Segarra, et al.
Published: (2024-04-01)

Prevalence and Molecular Mechanisms of Carbapenem Resistance among Gram-Negative Bacilli in Three Hospitals of Northern Lebanon
by: Mariam Rima, et al.
Published: (2022-09-01)

An update on carbapenem resistance in nonfermenting gram-negative bacteria
by: K V Sreejith, et al.
Published: (2023-01-01)

Carbapenem-Resistant Gram-Negative Bacilli Characterization in a Tertiary Care Center from El Bajio, Mexico
by: Jose Raul Nieto-Saucedo, et al.
Published: (2023-08-01)

Novel Antimicrobial Agents for Gram-Negative Pathogens
by: Marios Karvouniaris, et al.
Published: (2023-04-01)

Modern problems of antibiotic resistance gram-negative nosocomial infections in the Rostov region
by: O. Yu. Kutsevalova, et al.
Published: (2019-10-01)

Antimicrobial resistance of Gram-negative pathogens of nosocomial pneumonia in intensive care unit patients
by: Pervukhin S.A., et al.
Published: (2019-02-01)

Editorial: Multidrug gram-negative bacilli : current situation and future perspective
by: Luis Esaú López-Jácome, et al.
Published: (2023-11-01)

Carbapenemase-producing Gram-negative bacteria in aquatic environments: a review
by: Zineb Cherak, et al.
Published: (2021-06-01)

Beyond antibiotics: phage-encoded lysins against Gram-negative pathogens
by: Sanket Shah, et al.
Published: (2023-09-01)

Carbapenemase Producers Among Extensive Drug-Resistant Gram-Negative Pathogens Recovered from Febrile Neutrophilic Patients in Egypt
by: Mabrouk S, et al.
Published: (2020-09-01)

Carbapenemase-producing Gram-negative bacteria in the Russian research center of radiology and surgical technologies
by: Polishchuk A.G., et al.
Published: (2017-08-01)

Antimicrobial resistance of gram-negative pathogens isolated from hospitalized patients in Rostov region
by: Kutsevalova O.Yu., et al.
Published: (2020-05-01)

Carbapenem-resistant Gram-negative bacteria – analysis of the data obtained through a mandatory reporting system in the Rhine-Main region, Germany, 2012–2015
by: Heudorf, Ursel, et al.
Published: (2016-04-01)

Editorial: The global threat of carbapenem-resistant gram-negative bacteria, volume II
by: Ziad Daoud, et al.
Published: (2023-04-01)

Resistance trends in gram-negative bacteria: surveillance results from two Mexican hospitals, 2005–2010
by: Morfin-Otero Rayo, et al.
Published: (2012-06-01)

Detection and characterization of carbapenem resistant Gram‐negative bacilli isolates recovered from hospitalized patients at Soba University Hospital, Sudan
by: Hana S. Elbadawi, et al.
Published: (2021-05-01)

Treatment of Infections Due to MDR Gram-Negative Bacteria
by: Matteo Bassetti, et al.
Published: (2019-04-01)

Is It Possible to Eradicate Carbapenem-Resistant <i>Acinetobacter baumannii</i> (CRAB) from Endemic Hospitals?
by: Filippo Medioli, et al.
Published: (2022-07-01)

Evaluation with E-test of the meropenem/vaborbactam association in carbapenem-resistant and sensitive negative control strains isolates of samples processed at the Laboratory of the Rivoli Hospital
by: Giuseppina Amarù, et al.
Published: (2022-05-01)

Treatment of Multi-Drug Resistant Gram-Negative Bacterial Pathogenic Infections
by: Wardah Mohammad Akram, et al.
Published: (2020-09-01)

The Simplified Carbapenem Inactivation Method (sCIM) for Simple and Accurate Detection of Carbapenemase-Producing Gram-Negative Bacilli
by: Xiaopeng Jing, et al.
Published: (2018-10-01)

Results on the mandatory notification of carbapenem-resistant Gram-negative bacteria, Hesse, Germany, January 2012 – April 2013
by: Hauri, Anja M., et al.
Published: (2014-04-01)

Ceftazidime-Avibactam Combination Therapy versus Monotherapy for the Treatment Carbapenem-Resistant Gram-Negative Bacterial Infections: A Retrospective Observational Study
by: Li K, et al.
Published: (2024-03-01)

Prevalence of non-fermenting Gram-negative bacilli and their in vitro susceptibility pattern at a tertiary care teaching hospital
by: Kirtilaxmi K Benachinmardi, et al.
Published: (2014-01-01)

Carbapenemase Producing Gram-Negative Bacteria in Tunisia: History of Thirteen Years of Challenge
by: Dziri O, et al.
Published: (2020-11-01)

Evaluation of post-antibiotic effect in Gram-negative and Gram-positive bacteria
by: Elisa Tavella, et al.
Published: (2008-03-01)

Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii
by: Sara Alosaimy, et al.
Published: (2022-10-01)

Resistance mechanisms for Gram-negative bacteria-specific lipopeptides, turnercyclamycins, differ from that of colistin
by: Albebson L. Lim, et al.
Published: (2023-12-01)

Cefiderocol use in Gram negative infections with limited therapeutic options: Is combination therapy the key?
by: Silvia Corcione, et al.
Published: (2022-09-01)

Impact of Polymyxin Resistance on Virulence and Fitness among Clinically Important Gram-Negative Bacteria
by: Yuan Wang, et al.
Published: (2022-06-01)

Emergence of Carbapenem-Resistant Gram-Negative Isolates in Hospital Settings in Djibouti
by: Ayan Ali Ragueh, et al.
Published: (2023-06-01)

Antimicrobial Resistance and Resistance Determinant Insights into Multi-Drug Resistant Gram-Negative Bacteria Isolates from Paediatric Patients in China
by: Patil S, et al.
Published: (2019-11-01)

Investigation of Extended-Spectrum β-Lactamase and Carbapenemase Producing Gram-Negative Bacilli in Rectal Swabs Collected from Neonates and Their Associated Factors in Neonatal Intensive Care Units of Southern Ethiopia
by: Zakir A, et al.
Published: (2021-09-01)

Thymine Sensitizes Gram-Negative Pathogens to Antibiotic Killing
by: Yuan Liu, et al.
Published: (2021-01-01)

The threat of carbapenem-resistant gram-negative bacteria in a Middle East region
by: Davoudi-Monfared E, et al.
Published: (2018-10-01)

Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections
by: Amer El Ghali, et al.
Published: (2024-02-01)

Colistin-resistant Gram-negative bacteria in Saudi Arabia: A literature review
by: Abdulaziz Alqasim
Published: (2021-12-01)